{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:29:10Z","timestamp":1740173350388,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017661","name":"China Health Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ymgmr.2024.101102","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T12:57:19Z","timestamp":1717505839000},"page":"101102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fabry disease caused by the GLA p.Gly183Asp (p.G183D) variant: Clinical profile of a serious phenotype"],"prefix":"10.1016","volume":"40","author":[{"given":"Zhiquan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2024.101102_bb0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2022.07.010","article-title":"An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease","volume":"137","author":"Germain","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101102_bb0025","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s11011-023-01216-4","article-title":"Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families","volume":"38","author":"Cianci","year":"2023","journal-title":"Metab. Brain Dis."},{"issue":"12","key":"10.1016\/j.ymgmr.2024.101102_bb0080","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/BF03401993","article-title":"Twenty novel mutations in the alpha-galactosidase a gene causing Fabry disease","volume":"5","author":"Topaloglu","year":"1999","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101102_bb0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004728-200403000-00002","article-title":"Fabry disease: renal sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotypes","volume":"28","author":"Glass","year":"2004","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101102_bb0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101102_bb0100","first-page":"716","article-title":"Fabry disease: renal biopsy-proven cases from China","volume":"20","author":"Zhang","year":"2007","journal-title":"J. Nephrol."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101102_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107585","article-title":"An expert consensus on the recommendations for the use of biomarkers in Fabry disease","volume":"139","author":"Burlina","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2024.101102_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.ymgmr.2024.101102_bb0045","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101102_bb0070","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.20144","article-title":"Detection of\u202f?-galactosidase a mutations causing fabry disease by denaturing high performance liquid chromatography","volume":"25","author":"Shabbeer","year":"2005","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101102_bb0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ymgme.2019.07.012","article-title":"Founder effect of Fabry disease due to p.F113L mutation: clinical profile of a late-onset phenotype","volume":"129","author":"Azevedo","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2024.101102_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.amjcard.2022.05.021","article-title":"Value of electrocardiography to distinguish Fabry disease from sarcomeric hypertrophic cardiomyopathy","volume":"178","author":"Antezana-Chavez","year":"2022","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101102_bb0090","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/heartjnl-2020-318271","article-title":"Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy","volume":"108","author":"Vitale","year":"2022","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.ymgmr.2024.101102_bb0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.echo.2015.05.002","article-title":"Recommendations on the use of echocardiography in adult hypertension: a report from the european association of cardiovascular imaging (EACVI) and the american society of echocardiography (ASE)\u2020","volume":"28","author":"Marwick","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101102_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd9010011","article-title":"Electrocardiographic characteristics and their correlation with echocardiographic alterations in Fabry disease","volume":"9","author":"Zada","year":"2022","journal-title":"J. Cardiovas. Develop. Disease"},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2024.101102_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1096-7192(02)00151-8","article-title":"Structural basis of Fabry disease","volume":"77","author":"Garman","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgmr.2024.101102_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084267","article-title":"Comparative study of structural changes caused by different substitutions at the same residue on \u03b1-galactosidase a","volume":"8","author":"Saito","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ymgmr.2024.101102_bb0075","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10038-008-0316-9","article-title":"Structural characterization of mutant \u03b1-galactosidases causing Fabry disease","volume":"53","author":"Sugawara","year":"2008","journal-title":"J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ymgmr.2024.101102_bb0060","article-title":"Fabry disease: definition, incidence, clinical presentations and treatment - focus on cardiac involvement","volume":"38","author":"Saeed","year":"2022","journal-title":"Pakistan J. Med. Sci."},{"key":"10.1016\/j.ymgmr.2024.101102_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.carpath.2018.11.002","article-title":"Lysosomal storage disorders affecting the heart: a review","volume":"39","author":"Nair","year":"2019","journal-title":"Cardiovasc. Pathol."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T19:35:13Z","timestamp":1723923313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":20,"alternative-id":["S2214426924000557"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101102","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabry disease caused by the GLA p.Gly183Asp (p.G183D) variant: Clinical profile of a serious phenotype","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101102"}}